AJSM - 2026-03-21 - Journal Article
Failure Rates of SLAP Repair Compared With Subpectoral Biceps Tenodesis for Young Military Patients With Type 2 SLAP at 10-Year Follow-up.
Scanaliato JP, Sandler AB, Darwish B, Gilat R, Tyler JR, Parnes N
Topics
Key Takeaway
At minimum 10-year follow-up, 40% of SLAP repairs failed and required revision to tenodesis, versus 0% revision rate in the primary subpectoral biceps tenodesis group.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study compared arthroscopic SLAP repair versus mini-open subpectoral biceps tenodesis for type 2 SLAP tears in active-duty military patients under 35 at minimum 10-year follow-up. Ten of 25 SLAP repair patients (40%) failed and were revised to tenodesis at a mean of 68.7 months, while zero tenodesis patients required revision. Even among successful SLAP repairs, tenodesis patients achieved significantly higher rates of SCB for VAS (100% vs 33.3%) and PASS/SCB for SANE scores.
Key Limitation
Small sample size (n=48) with non-randomized, surgeon-directed treatment allocation based on biceps symptomatology creates selection bias and limits generalizability beyond the military population.
Original Abstract
BACKGROUND
Recent evidence has demonstrated short-term superiority of biceps tenodesis compared to superior labrum anterior-posterior (SLAP) repair for the management of symptomatic type 2 SLAP tears. Long-term comparative patient-reported outcomes and revision rates remain poorly described.
PURPOSE
To compare minimum 10-year outcomes of arthroscopic SLAP repair with those of mini-open subpectoral biceps tenodesis for type 2 SLAP tears in active-duty military patients younger than 35 years of age.
STUDY DESIGN
Cohort study; Level of evidence, 3.
METHODS
Consecutive active-duty military servicemembers younger than 35 years of age at the time of surgery who underwent arthroscopic SLAP repair or mini-open subpectoral biceps tenodesis for type 2 SLAP tears between January 2010 and December 2015 with at least 10 years of follow-up were included. SLAP repair was performed if preoperative biceps testing did not elicit pain and, intraoperatively, the tendon appeared clinically normal. All other patients underwent biceps tenodesis. Patient characteristics, patient-reported outcome measures, range of motion, complications, and return to military duty were assessed.
RESULTS
In total, 25 patients who underwent arthroscopic SLAP repair and 23 who underwent biceps tenodesis were included (mean follow-up, 146.5 ± 18.7 months). Ten patients (40%) for whom SLAP repair failed were analyzed separately from those who did not experience failure. Pain visual analog scale (VAS), Single Assessment Numeric Evaluation (SANE), and American Shoulder and Elbow Surgeons scores improved significantly in the successful SLAP repair, failed SLAP repair, and tenodesis subgroups ( P < .0188), with greater improvements in the successful SLAP repair and tenodesis groups. When compared to successful SLAP repair, patients undergoing tenodesis were significantly more likely to achieve substantial clinical benefit (SCB) for VAS scores (100.0% vs 33.3%; P < .0001) and Patient Acceptable Symptom State (PASS) and SCB for SANE scores (95.7% vs 53.3% [ P = .0032] and 100.0% vs 13.3% [ P < .0001], respectively). All patients for whom SLAP repair failed were revised to tenodesis at a mean of 68.7 ± 48.9 months, while none of the patients initially treated with tenodesis required revision ( P = .0007).
CONCLUSION
At the minimum 10-year follow-up, 40% of the military cohort younger than 35 years of age treated with SLAP repair experienced treatment failure and underwent subsequent revision to biceps tenodesis, compared with no revisions in patients who underwent biceps tenodesis as the index procedure. Furthermore, even with successful SLAP repair, patient-reported outcomes were inferior to those after biceps tenodesis. Overall, this study suggests that biceps tenodesis is superior to SLAP repair for the treatment of type 2 SLAP tears in active-duty military patients younger than 35 years of age.